Literature DB >> 22886615

AKT as locus of cancer multidrug resistance and fragility.

Ziv Radisavljevic1.   

Abstract

Complexity and robustness of cancer hypoxic microenvironment are supported by the robust signaling networks of autocrine and paracrine elements creating powerful interactome for multidrug resistance. These elements generate a positive feedback loops responsible for the extreme robustness and multidrug resistance in solid cancer, leukemia, myeloma, and lymphoma. Phosphorylated AKT is a cancer multidrug resistance locus. Targeting that locus by oxidant/antioxidant balance modulation, positive feedback loops are converted into negative feedback loops, leading to disappearance of multidrug resistance. This is a new principle for targeting cancer multidrug resistance by the locus chemotherapy inducing a phenomenon of loops conversion.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22886615     DOI: 10.1002/jcp.24176

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation.

Authors:  Xiaojun Tan; Yue Sun; Narendra Thapa; Yihan Liao; Andrew C Hedman; Richard A Anderson
Journal:  EMBO J       Date:  2015-01-14       Impact factor: 11.598

2.  Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells.

Authors:  Zhongwei He; Xiangling Xiao; Shan Li; Yang Guo; Qiuyue Huang; Xin Shi; Xiaobo Wang; Ying Liu
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

3.  Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.

Authors:  Danyang Zhou; Wenjing Liu; Songhe Liang; Banghao Sun; Anqi Liu; Zhongqi Cui; Xue Han; Lijie Yuan
Journal:  Cancer Med       Date:  2018-03-09       Impact factor: 4.452

4.  Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.

Authors:  Lavinia Raimondi; Nicola Amodio; Maria Teresa Di Martino; Emanuela Altomare; Marzia Leotta; Daniele Caracciolo; Annamaria Gullà; Antonino Neri; Simona Taverna; Patrizia D'Aquila; Riccardo Alessandro; Antonio Giordano; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Oncotarget       Date:  2014-05-30

5.  Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors.

Authors:  Hisataka Kitano; Atsushi Mamiya; Tomomi Ishikawa; Kayo Egoshi; Shinichiro Kokubun; Chiaki Hidai
Journal:  Onco Targets Ther       Date:  2016-01-25       Impact factor: 4.147

6.  DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells.

Authors:  Wei Jing; Na Song; Yunpeng Liu; Xiujuan Qu; Kezuo Hou; Xianghong Yang; Xiaofang Che
Journal:  Mol Med Rep       Date:  2017-10-27       Impact factor: 2.952

7.  Overexpression of CIP2A is associated with poor prognosis in multiple myeloma.

Authors:  Xuewen Liu; Wei Cao; Shanshan Qin; Te Zhang; Junnian Zheng; Ying Dong; Pinghong Ming; Qian Cheng; Zheng Lu; Yang Guo; Baofu Zhang; Ying Liu
Journal:  Signal Transduct Target Ther       Date:  2017-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.